PubMed
- Autoantibodies are associated with negative interference in cardiac Troponin I assays
- Glycosylation of NT-proBNP Molecules and NT-proBNP Immunoassays
- NT-proBNP stability and sandwich immunoassays utilizing MAbs with different epitope specifity
- New sensitive sandwich assay for quantification of BNP in human blood
- ProBNP is a Major Form of BNP Immunoreactivity in Blood of Patients with Heart Failure
- Recombinant proBNP, Expressed in Eukaryotic Cells as a Stable Standard for BNP Immunoassay
- Rubella Polyvalent Vaccine Candidate Based on Chimeric hsp70 Containing Constructs
These PDF files can be viewed with Adobe Acrobat Reader .
External Publications
- Troponin I is released in bloodstream of patients with AMI not in free form but as complex
- Degradation of cardiac troponin I: implication for reliable immunodetection
- The BNP Precursor Is the Major Immunoreactive Form of BNP in Patients with Heart Failure
- Negative Interference in cTnI Immunoassays from a Frequently Occurring Serum and Plasma Component
- Comparison of Cardiac Troponin I Immunoassays Variably Affected by Circulating Autoantibodies
- Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies